222 related articles for article (PubMed ID: 9863490)
1. Prognostic factors in patients with endocrine tumours of the duodenopancreatic area.
Madeira I; Terris B; Voss M; Denys A; Sauvanet A; Flejou JF; Vilgrain V; Belghiti J; Bernades P; Ruszniewski P
Gut; 1998 Sep; 43(3):422-7. PubMed ID: 9863490
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
[TBL] [Abstract][Full Text] [Related]
4. Strategy for pancreatic endocrine tumors.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Demachi H; Miwa A
Hepatogastroenterology; 2000; 47(32):537-9. PubMed ID: 10791232
[TBL] [Abstract][Full Text] [Related]
5. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes.
Grama D; Eriksson B; Mårtensson H; Cedermark B; Ahrén B; Kristoffersson A; Rastad J; Oberg K; Akerström G
World J Surg; 1992; 16(4):632-9. PubMed ID: 1357829
[TBL] [Abstract][Full Text] [Related]
7. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
[TBL] [Abstract][Full Text] [Related]
8. Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours.
Falconi M; Bassi C; Bonora A; Sartori N; Procacci C; Talamini G; Mansueto GC; Pederzoli P
Dig Surg; 1999; 16(1):32-8. PubMed ID: 9949265
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis.
Poultsides GA; Huang LC; Chen Y; Visser BC; Pai RK; Jeffrey RB; Park WG; Chen AM; Kunz PL; Fisher GA; Norton JA
Ann Surg Oncol; 2012 Jul; 19(7):2295-303. PubMed ID: 22396008
[TBL] [Abstract][Full Text] [Related]
10. [Pancreatic endocrine tumors: clinical manifestations and predictive factors associated with survival].
Paik WH; Yoon YB; Lee SH; Park JK; Woo SM; Yang KY; Seo JK; Ryu JK; Kim YT
Korean J Gastroenterol; 2008 Sep; 52(3):171-8. PubMed ID: 19077513
[TBL] [Abstract][Full Text] [Related]
11. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.
Chok KS; Cheung TT; Chan AC; Dai WC; Chan SC; Fan ST; Poon RT; Lo CM
ANZ J Surg; 2014; 84(7-8):545-9. PubMed ID: 23809019
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of non-functioning pancreatic neuroendocrine tumours based on three clinical scenarios.
Busquets J; Ramírez-Maldonado E; Serrano T; Peláez N; Secanella L; Ruiz-Osuna S; Ramos E; Lladó L; Fabregat J
Cir Esp; 2016 Dec; 94(10):578-587. PubMed ID: 27863693
[TBL] [Abstract][Full Text] [Related]
13. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
14. Extended surgery for advanced pancreatic endocrine tumours.
Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
[TBL] [Abstract][Full Text] [Related]
15. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
[TBL] [Abstract][Full Text] [Related]
16. Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study.
Gullo L; Migliori M; Falconi M; Pederzoli P; Bettini R; Casadei R; Delle Fave G; Corleto VD; Ceccarelli C; Santini D; Tomassetti P
Am J Gastroenterol; 2003 Nov; 98(11):2435-9. PubMed ID: 14638345
[TBL] [Abstract][Full Text] [Related]
17. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
18. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas.
Bettini R; Mantovani W; Boninsegna L; Crippa S; Capelli P; Bassi C; Scarpa A; Pederzoli P; Falconi M
Dig Liver Dis; 2009 Jan; 41(1):49-55. PubMed ID: 18463008
[TBL] [Abstract][Full Text] [Related]
19. Liver metastases of digestive endocrine tumours: natural history and response to medical treatment.
Skinazi F; Zins M; Menu Y; Bernades P; Ruszniewski P
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):673-8. PubMed ID: 8853257
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
